Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingfeng Yu

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Future Medicinal Chemistry|February 25, 2016
Unveiling new chemical scaffolds as Mnk inhibitorsSarah Diab, Peng Li, Sunita K C Basnet, et al.
Quantitative Imaging in Medicine and Surgery|September 15, 2023
Optimization and validation of voxel size-related radiomics variability by combatting batch effect harmonization in pulmonary nodules: a phantom and clinical studyYaoyao Zhuo, Jie Shen, Yi Zhan, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|February 22, 2011
[Surgical treatment for locally advanced lung cancer invading heart and great vessels]Lin Xu, Fangliang Yuan, Mingfeng Yu, et al.
Oncotarget|July 28, 2016
Inhibition of Mnk enhances apoptotic activity of cytarabine in acute myeloid leukemia cellsPeng Li, Sarah Diab, Mingfeng Yu, et al.
Chemmedchem|November 18, 2022
Discovery of Potent Inhibitors of Cyclin-Dependent Kinases 7 and 9: Design, Synthesis, Structure-Activity Relationship Analysis and Biological EvaluationRenjie Chen, Ramin Hassankhani, Yi Long, et al.
European Journal of Medicinal Chemistry|January 31, 2021
Discovery of novel 4-azaaryl-N-phenylpyrimidin-2-amine derivatives as potent and selective FLT3 inhibitors for acute myeloid leukaemia with FLT3 mutationsYi Long, Mingfeng Yu, Aleksandra M Ochnik, et al.
Experimental Neurology|June 17, 2026
From molecular mechanisms to clinical implications of clock genes in ischemic stroke: A scoping reviewSuya Li, Keqin Liu, Yingying Lv, et al.
Journal of Medicinal Chemistry|May 24, 2016
Nontoxic Metal-Cyclam Complexes, a New Class of Compounds with Potency against Drug-Resistant Mycobacterium tuberculosisMingfeng Yu, Gayathri Nagalingam, Samantha Ellis, et al.
Dalton Transactions (Cambridge, England : 2003)|February 26, 2021
Copper(ii) complexes of N-propargyl cyclam ligands reveal a range of coordination modes and colours, and unexpected reactivityAndrew J Counsell, Mingfeng Yu, Mengying Shi, et al.
Bioorganic & Medicinal Chemistry Letters|August 1, 2019
Synthesis and evaluation of 2'H-spiro[cyclohexane-1,3'-imidazo[1,5-a]pyridine]-1',5'-dione derivatives as Mnk inhibitorsAhmed M Abdelaziz, Sunita K C Basnet, Saiful Islam, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Future Medicinal Chemistry|February 25, 2016
Unveiling new chemical scaffolds as Mnk inhibitorsSarah Diab, Peng Li, Sunita K C Basnet, et al.
Quantitative Imaging in Medicine and Surgery|September 15, 2023
Optimization and validation of voxel size-related radiomics variability by combatting batch effect harmonization in pulmonary nodules: a phantom and clinical studyYaoyao Zhuo, Jie Shen, Yi Zhan, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|February 22, 2011
[Surgical treatment for locally advanced lung cancer invading heart and great vessels]Lin Xu, Fangliang Yuan, Mingfeng Yu, et al.
Oncotarget|July 28, 2016
Inhibition of Mnk enhances apoptotic activity of cytarabine in acute myeloid leukemia cellsPeng Li, Sarah Diab, Mingfeng Yu, et al.
Chemmedchem|November 18, 2022
Discovery of Potent Inhibitors of Cyclin-Dependent Kinases 7 and 9: Design, Synthesis, Structure-Activity Relationship Analysis and Biological EvaluationRenjie Chen, Ramin Hassankhani, Yi Long, et al.
European Journal of Medicinal Chemistry|January 31, 2021
Discovery of novel 4-azaaryl-N-phenylpyrimidin-2-amine derivatives as potent and selective FLT3 inhibitors for acute myeloid leukaemia with FLT3 mutationsYi Long, Mingfeng Yu, Aleksandra M Ochnik, et al.
Experimental Neurology|June 17, 2026
From molecular mechanisms to clinical implications of clock genes in ischemic stroke: A scoping reviewSuya Li, Keqin Liu, Yingying Lv, et al.
Journal of Medicinal Chemistry|May 24, 2016
Nontoxic Metal-Cyclam Complexes, a New Class of Compounds with Potency against Drug-Resistant Mycobacterium tuberculosisMingfeng Yu, Gayathri Nagalingam, Samantha Ellis, et al.
Dalton Transactions (Cambridge, England : 2003)|February 26, 2021
Copper(ii) complexes of N-propargyl cyclam ligands reveal a range of coordination modes and colours, and unexpected reactivityAndrew J Counsell, Mingfeng Yu, Mengying Shi, et al.
Bioorganic & Medicinal Chemistry Letters|August 1, 2019
Synthesis and evaluation of 2'H-spiro[cyclohexane-1,3'-imidazo[1,5-a]pyridine]-1',5'-dione derivatives as Mnk inhibitorsAhmed M Abdelaziz, Sunita K C Basnet, Saiful Islam, et al.
Pageof 6